首页> 外文期刊>Canadian Journal of Physiology and Pharmacology >The source of heme for vascular heme oxygenase II: de novo heme biosynthesis in rat aorta.
【24h】

The source of heme for vascular heme oxygenase II: de novo heme biosynthesis in rat aorta.

机译:血管血红素加氧酶II的血红素来源:大鼠主动脉从头开始的血红素生物合成。

获取原文
获取原文并翻译 | 示例
           

摘要

Heme is an essential prosthetic group or substrate for many proteins, including hemoglobin, and hemo enzymes such as nitric oxide synthase, soluble guanylyl cyclase, and heme oxygenase (HO). HO is responsible for the breakdown of heme into equimolar amounts of biliverdin, iron, and carbon monoxide, the latter of which is thought to play a role in the regulation of vascular tone. It is not clear whether the source of heme for cardiovascular functions is derived from uptake from the extracellular milieu or synthesis. In this study, we tested the hypothesis that blood vessels obtain their supply of heme for HO through de novo synthesis. Adult male Sprague–Dawley rat aorta was incubated at 37 degrees C in Krebs' solution with 1 micro M [14C]δ-aminolevulinic acid (ALA). [14C]ALA uptake was linear for about 30 min and reached a plateau at approximately 100 min. The radioactivity was incorporated into porphyrins and heme as determined by esterification of 14C-labelled metabolites and thin-layer chromatography. The first and rate-limiting step of heme biosynthesis is catalyzed by ALA synthase (ALA-S), the activity of which was determined in rat aorta using a radiometric assay, ~250 nmol.(g wet mass)–1.h–1. Inducing HO-1 in rat aorta with S-nitroso-N-acetyl penicil la mine (500 micro M) did not increase ALA-S activity as compared with basal activity levels of the enzyme. It appears that there is a sufficient amount of heme available under basal ALA-S activity conditions to meet the increased demand for heme resulting from HO-1 induction. These observations indicate that the complete enzymatic pathway for de novo heme biosynthesis resides in rat aorta and furthermore indicate that de novo heme synthesis is capable of supplying a substantial portion of the heme substrate for HO in the aorta.
机译:血红素是许多蛋白质(包括血红蛋白)和血液酶(例如一氧化氮合酶,可溶性鸟苷酸环化酶和血红素加氧酶(HO))的必不可少的修复基团或底物。 HO负责将血红素分解成等摩尔量的biliverdin,铁和一氧化碳,后者被认为在调节血管紧张度中起作用。尚不清楚心血管功能血红素的来源是否源自细胞外环境的摄取或合成。在这项研究中,我们检验了以下假设:血管通过从头合成获得了血红素的HO供应。成年雄性Sprague–Dawley大鼠主动脉在Krebs溶液中与1 micro M [14C]δ-氨基乙酰丙酸(ALA)一起于37摄氏度孵育。 [14C] ALA摄取呈线性持续约30分钟,并在约100分钟达到平稳。通过14C标记的代谢物的酯化和薄层色谱法测定,将放射性掺入卟啉和血红素中。血红素生物合成的第一步和限速步骤是通过ALA合酶(ALA-S)催化的,ALA合成酶的活性是通过放射测定法在大鼠主动脉中测定的,〜250 nmol。(g湿质量)–1.h–1 。与酶的基础活性水平相比,用S-亚硝基-N-乙酰青霉素(500 micro M)诱导大鼠主动脉中的HO-1不会增加ALA-S活性。似乎在基础ALA-S活性条件下有足够数量的血红素可用于满足HO-1诱导引起的血红素需求的增加。这些观察结果表明,从头血红素生物合成的完整酶促途径位于大鼠主动脉中,此外,表明从头血红素合成能够为主动脉中的HO提供血红素底物的大部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号